- Home
- ALLE vs ICLR Comparison
ALLE vs ICLR Comparison
Compare ALLE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- ICLR
- Stock Information
- Founded
- ALLE 2013
- ICLR 1990
- Country
- ALLE Ireland
- ICLR Ireland
- Employees
- ALLE N/A
- ICLR N/A
- Industry
- ALLE Diversified Commercial Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ALLE Consumer Discretionary
- ICLR Health Care
- Exchange
- ALLE Nasdaq
- ICLR Nasdaq
- Market Cap
- ALLE 11.9B
- ICLR 11.4B
- IPO Year
- ALLE N/A
- ICLR 1998
- Fundamental
- Price
- ALLE $137.58
- ICLR $146.48
- Analyst Decision
- ALLE Hold
- ICLR Buy
- Analyst Count
- ALLE 5
- ICLR 12
- Target Price
- ALLE $140.40
- ICLR $204.18
- AVG Volume (30 Days)
- ALLE 856.9K
- ICLR 1.1M
- Earning Date
- ALLE 07-23-2025
- ICLR 07-23-2025
- Dividend Yield
- ALLE 1.48%
- ICLR N/A
- EPS Growth
- ALLE 16.19
- ICLR 11.53
- EPS
- ALLE 7.12
- ICLR 9.19
- Revenue
- ALLE $3,820,200,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- ALLE $5.99
- ICLR N/A
- Revenue Next Year
- ALLE $4.70
- ICLR $2.10
- P/E Ratio
- ALLE $19.21
- ICLR $15.62
- Revenue Growth
- ALLE 5.48
- ICLR N/A
- 52 Week Low
- ALLE $113.27
- ICLR $125.10
- 52 Week High
- ALLE $156.10
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- ALLE 46.90
- ICLR 58.35
- Support Level
- ALLE $134.68
- ICLR $140.20
- Resistance Level
- ALLE $140.46
- ICLR $147.26
- Average True Range (ATR)
- ALLE 2.18
- ICLR 5.06
- MACD
- ALLE -0.56
- ICLR 1.39
- Stochastic Oscillator
- ALLE 34.68
- ICLR 85.25
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.